How does a person meet criteria for depersonalization‑derealization disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Depersonalization-Derealization Disorder

A person meets criteria for depersonalization-derealization disorder when they experience persistent or recurrent episodes of feeling detached from themselves (depersonalization) or their surroundings (derealization), while maintaining intact reality testing, and these symptoms cause significant distress or functional impairment.

Core Diagnostic Requirements

The diagnosis requires three essential components based on DSM criteria 1, 2:

1. Presence of Depersonalization and/or Derealization Symptoms

Depersonalization manifests as:

  • Feeling detached from one's own thoughts, feelings, sensations, or body
  • Experiencing oneself as an outside observer of one's mental processes or body
  • Feeling like an automaton or living in a dream
  • Emotional numbness or blunted affect
  • Tactile imagery disturbances (reported in 50% of cases) 3
  • Disrupted self-environmental integration (42% of cases) 3
  • Impaired dream-reality integration (28% of cases) 3

Derealization presents as:

  • Experiencing surroundings as unreal, dreamlike, foggy, or visually distorted
  • Feeling detached or estranged from one's environment
  • Perceiving people or objects as unfamiliar or artificial

2. Preserved Reality Testing

This is the critical distinguishing feature: the person knows these experiences are not real 4. They retain insight that these are perceptual distortions, not actual changes in reality. This differentiates depersonalization-derealization disorder from psychotic disorders where reality testing is impaired.

3. Clinical Significance

The symptoms must cause:

  • Clinically significant distress, OR
  • Impairment in social, occupational, or other important areas of functioning 1

Duration and Persistence Requirements

  • Symptoms must be persistent or recurrent 2, 5
  • The disorder tends to be chronic, with mean duration of approximately 6 years before presentation 3
  • Mean age of onset is 22.8 years, with earlier onset associated with greater severity 1

Exclusion Criteria

The diagnosis cannot be made if symptoms are:

  • Better explained by another mental disorder (e.g., schizophrenia, panic disorder, acute stress disorder, PTSD, another dissociative disorder)
  • Attributable to the physiological effects of a substance (medication, drug of abuse) or another medical condition 4

Important caveat: While psychedelic drugs or cannabis can precipitate the disorder, if symptoms persist chronically after drug elimination, the diagnosis of depersonalization-derealization disorder is appropriate 4. The drug acts as a catalyst in vulnerable individuals rather than the sole cause.

Screening and Detection

For clinical screening purposes 6:

  • Dissociative Experiences Scale (DES) cutoff score of 12 or higher (notably lower than cutoffs for other dissociative disorders)
  • The DES-taxon score shows better sensitivity for detecting depersonalization-derealization disorder
  • Clinically significant dpdr can be defined as endorsing depersonalization and/or derealization "sometimes" or "often" in the past month 7

Common Clinical Patterns

Primary vs. Secondary Presentation 1:

  • 71% of cases meet criteria for primary depersonalization-derealization disorder (not better explained by another condition)
  • The remaining cases have depersonalization-derealization secondary to other psychiatric conditions

Comorbidity considerations 1, 7:

  • High comorbidity with anxiety (depersonalization scores correlate with anxiety levels)
  • High comorbidity with depression
  • More likely when both mood and anxiety disorders coexist (11.8% of comorbid cases vs. 0% in isolated generalized anxiety disorder) 7
  • Associated with number of comorbid disorders rather than any single disorder
  • "Dissociative amnesia" is not prominent in this disorder 1

Diagnostic Pitfalls to Avoid

  1. Don't confuse with psychosis: The preserved insight and reality testing is pathognomonic—patients know their experiences aren't real 4

  2. Don't dismiss chronic cases as "drug-induced": While substances can trigger onset, persistent symptoms represent a distinct disorder requiring treatment, not simply prolonged drug effects 4

  3. Don't overlook the diagnosis: It's frequently underdiagnosed and undercoded, possibly due to patients' difficulty articulating symptoms or clinicians misinterpreting them 3

  4. Don't require dissociative amnesia: Unlike other dissociative disorders, amnesia is not a prominent feature 1

  5. Screen with appropriate thresholds: Use DES cutoff of 12, not the higher cutoffs used for other dissociative disorders 6

The diagnosis requires clinical judgment integrating symptom phenomenology, duration, functional impact, and careful exclusion of other causes, with particular attention to the characteristic "as-if" quality of experiences where the person maintains awareness that their perceptions are distorted 4.

References

Research

Depersonalisation disorder: clinical features of 204 cases.

The British journal of psychiatry : the journal of mental science, 2003

Research

Psychedelic-Associated Depersonalization-Derealization Disorder.

Current topics in behavioral neurosciences, 2025

Research

The Treatment of Depersonalization-Derealization Disorder: A Systematic Review.

Journal of trauma & dissociation : the official journal of the International Society for the Study of Dissociation (ISSD), 2024

Research

The detection and measurement of depersonalization disorder.

The Journal of nervous and mental disease, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.